Beijing Sun Novo Pharmaceutical Research Co Ltd Cash Flow-to-Debt Ratio
Beijing Sun Novo Pharmaceutical Research Co Ltd cash flow-to-debt ratio. Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of CN¥76.07 Million could theoretically repay 0% of its total liabilities (CN¥1.05 Billion) in one year. Check Beijing Sun Novo Pharmaceutical Research earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)
Cash flow-to-debt ratio of Beijing Sun Novo Pharmaceutical Research Co Ltd from 2017 to 2025. Historical debt coverage capacity for Beijing Sun Novo Pharmaceutical Research Co Ltd across 9 annual periods. Check Beijing Sun Novo Pharmaceutical Research investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Beijing Sun Novo Pharmaceutical Research Co Ltd Cash Flow-to-Debt Ratio by Year (2017–2025)
Beijing Sun Novo Pharmaceutical Research Co Ltd cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Beijing Sun Novo Pharmaceutical Research Co Ltd. For the full cash flow conversion analysis, see 688621 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥93.21 Million | CN¥1.05 Billion | ▲ +145.0% |
| 2024 | 0.04x | CN¥32.02 Million | CN¥884.65 Million | ▼ -68.6% |
| 2023 | 0.12x | CN¥92.86 Million | CN¥805.76 Million | ▼ -38.5% |
| 2022 | 0.19x | CN¥103.96 Million | CN¥554.86 Million | ▲ +0.4% |
| 2021 | 0.19x | CN¥88.25 Million | CN¥473.01 Million | ▼ -43.2% |
| 2020 | 0.33x | CN¥62.99 Million | CN¥191.94 Million | ▼ -3.9% |
| 2019 | 0.34x | CN¥56.97 Million | CN¥166.76 Million | ▼ -1.1% |
| 2018 | 0.35x | CN¥44.11 Million | CN¥127.68 Million | ▲ +231.3% |
| 2017 | 0.10x | CN¥8.01 Million | CN¥76.82 Million | — |